Clinical Trial Detail

NCT ID NCT01949883
Title A Phase 1 Study Evaluating CPI-0610 in Patients With Progressive Lymphoma
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements no
Sponsors Constellation Pharmaceuticals
Indications

non-Hodgkin lymphoma

Hodgkin's lymphoma

Therapies

CPI-0610

Age Groups: adult

No variant requirements are available.